论文部分内容阅读
肺炎支原体是小儿呼吸道感染的常见病原,可引起全呼吸道的感染性炎症,并可累积多系统损害,且缺乏特异性,因此对于肺炎支原体感染同时并发的其它系统损害,较容易诊断,但以呼吸系统以外的其它系统损害为首发或主要表现的病例,诊断较为困难,应及时进行血清特异性抗体的检测,目前特异性抗体检测(IgM和IgG)是确诊肺炎支原体感染的标准之一,但仍受诸多因素影响,多媒体医学显微诊断仪(MCMDI)为早期快速诊断提供了一种新方法,故各种检测方法阳性结果只能作为诊断肺炎支原体感染的依据。在治疗上选用对干扰蛋白质合成或DNA合成的抗生素,如大环内脂类。对有多系统损害者,可应用肾上腺糖皮质激素、NO合成抑制剂、TNF-α拮抗剂等对症治疗。
Mycoplasma pneumoniae is a common cause of respiratory tract infection in children and can cause infectious inflammation of the whole respiratory tract, and can accumulate multiple system damage, and the lack of specificity, so concurrent Mycoplasma pneumoniae infection complicated by other systems, easier to diagnose, but to breathe System other than the system damage as the first or the main performance of the case, the diagnosis is more difficult, serum-specific antibodies should be promptly detected, the current specific antibody test (IgM and IgG) is one of the criteria for the diagnosis of Mycoplasma pneumoniae infection, but still Influenced by many factors, the multimedia medical microscope (MCMDI) provides a new method for rapid early diagnosis. Therefore, the positive results of various detection methods can only be used as the basis for diagnosis of Mycoplasma pneumoniae infection. Antibiotics that interfere with protein synthesis or DNA synthesis, such as macrolides, are used therapeutically. Symptomatic treatment of multiple system damage, such as glucocorticoid glucocorticoid, NO synthesis inhibitors, TNF-α antagonists and other symptomatic treatment.